Literature DB >> 7641355

Long-term (5-year) changes in HDL cholesterol in cardiac rehabilitation patients. Do sex differences exist?

J G Warner1, P H Brubaker, Y Zhu, T M Morgan, P M Ribisl, H S Miller, D M Herrington.   

Abstract

BACKGROUND: It is unknown whether the benefits of a cardiac rehabilitation program on HDL cholesterol (HDL-C) are equally achieved in men and women. To study this, we compared changes in HDL-C and other lipids in a large group of men and women participating in a cardiac rehabilitation program for up to 5 years. METHODS AND
RESULTS: We compared changes in HDL-C and other fasting lipids in 553 men and 166 women participating in a cardiac rehabilitation program at baseline and then annually for up to 5 years. Patients exercised 3 days a week at 70% to 85% of their maximum heart rate predetermined by a symptom-limited treadmill test. Aerobic capacity was estimated in metabolic equivalents (METs), and percent body fat was determined by skin-fold measurements. Baseline HDL-C, LDL cholesterol (LDL-C), and total cholesterol were significantly higher in women, whereas the ratio of total cholesterol to HDL-C was lower. Although both men and women showed an increase in HDL-C after 1 year (10% and 7%, respectively), only the women's level continued to increase over 5 years (20% versus 5% for men, P = .03). The sex difference in change in HDL-C remained after adjustment for age and smoking. A nonsignificant trend toward a greater change in HDL-C in women existed after adjustment for baseline percent body fat and estimated METs. The change in the ratio of total cholesterol to HDL-C was also more favorable in women, with a 38% decrease over 5 years compared with a 14% decrease in men (P = .01). Total cholesterol decreased by 20% in women and 8% in men (P = .001), whereas LDL-C dropped by 34% in women and 15% in men (P = .0001). There was no sex difference in change in triglycerides.
CONCLUSIONS: Women with heart disease who participate in a cardiac rehabilitation program may achieve greater lipid benefits over longer periods of time than previously demonstrated in men.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7641355     DOI: 10.1161/01.cir.92.4.773

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.

Authors:  Samia Mora; Julie E Buring; Paul M Ridker; Yadong Cui
Journal:  Ann Intern Med       Date:  2011-12-06       Impact factor: 25.391

Review 2.  The effect of hormone replacement therapy and exercise on cardiovascular disease risk factors in postmenopausal women.

Authors:  B L Haddock; H P Marshak; J J Mason; G Blix
Journal:  Sports Med       Date:  2000-01       Impact factor: 11.136

Review 3.  Treatment of dyslipidemia in pre- and postmenopausal women with and without known atherosclerotic cardiovascular disease.

Authors:  V Bittner
Journal:  Curr Cardiol Rep       Date:  2001-09       Impact factor: 2.931

4.  Is there any difference between non-obese male and female in response to cardiac rehabilitation programs?

Authors:  Masoumeh Sadeghi; Fatemeh E Ghashghaei; Katayoun Rabiei; Hamidreza Roohafza; Hamid Afshar
Journal:  J Res Med Sci       Date:  2012-08       Impact factor: 1.852

5.  Cardiac rehabilitation: a comprehensive review.

Authors:  Scott A Lear; Andrew Ignaszewski
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.